EGLU ((2S)-α-ethylglutamic acid ) is a drug that is used in neuroscience research. It was one of the first compounds found that acts as a selective antagonist for the group II metabotropic glutamate receptors (mGluR2/3), and so has been useful in the characterization and study of this receptor subfamily.[1][2][3][4][5][6][7]
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID |
|
IUPHAR/BPS |
|
ChemSpider |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C7H13NO4 |
Molar mass | 175.184 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |